0000950103-22-010949.txt : 20220621
0000950103-22-010949.hdr.sgml : 20220621
20220621173358
ACCESSION NUMBER: 0000950103-22-010949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220616
FILED AS OF DATE: 20220621
DATE AS OF CHANGE: 20220621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bonita David P
CENTRAL INDEX KEY: 0001572451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39430
FILM NUMBER: 221029195
MAIL ADDRESS:
STREET 1: C/O ORBIMED ADVISORS LLC
STREET 2: 601 LEXINGTON AVENUE, 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acutus Medical, Inc.
CENTRAL INDEX KEY: 0001522860
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 451306615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2210 FARADAY AVE
STREET 2: SUITE 100
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 442-232-6080
MAIL ADDRESS:
STREET 1: 2210 FARADAY AVE
STREET 2: SUITE 100
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
dp175617_4-bonita.xml
FORM 4
X0306
4
2022-06-16
0
0001522860
Acutus Medical, Inc.
AFIB
0001572451
Bonita David P
C/O ACUTUS MEDICAL, INC.
2210 FARADAY AVE., SUITE 100
CARLSBAD
CA
92008
1
0
1
0
Common Stock
2022-06-16
4
A
0
8400
0
A
12422
D
Common Stock
4872025
I
See footnotes
Common Stock
1677361
I
See footnotes
Stock Options (Right to Buy)
0.5036
2022-06-16
4
A
0
19600
0
A
2032-06-16
Common Stock
19600
19600
D
Each annual restricted stock unit ("Annual RSU") will be scheduled to vest as to all of the shares of Common Stock ("Shares") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the Reporting Person has remained in continuous service as a director.
These shares of the Issuer's common stock are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV, and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the managing member of GP IV. OrbiMed Advisors and GP IV exercise investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OPI IV. The Reporting Person is a member of OrbiMed Advisors.
These shares of the Issuer's common stock are held of record by OrbiMed Royalty Opportunities II, LP ("ORO II"). OrbiMed ROF II LLC ("ROF II") is the general partner of ORO II, and OrbiMed Advisors is the managing member of ORO II. OrbiMed Advisors and ROF II exercise investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by ORO II.
Each of the Reporting Person, OrbiMed Advisors, ROF II, and GP IV disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Person, is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes.
Each annual stock option (the "Annual Option") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the Reporting Person has remained in continuous service as a director.
/s/ Tom Sohn as attorney-in-fact for David P. Bonita
2022-06-21